Wells Fargo & Company Biomerica Inc Transaction History
Wells Fargo & Company
- $407 Billion
- Q2 2024
A detailed history of Wells Fargo & Company transactions in Biomerica Inc stock. As of the latest transaction made, Wells Fargo & Company holds 6,580 shares of BMRA stock, worth $2,237. This represents 0.0% of its overall portfolio holdings.
Number of Shares
6,580
Previous 6,620
0.6%
Holding current value
$2,237
Previous $5,000
60.0%
% of portfolio
0.0%
Previous 0.0%
Shares
18 transactions
Others Institutions Holding BMRA
# of Institutions
38Shares Held
2.4MCall Options Held
0Put Options Held
0-
Granahan Investment Management, LLC Waltham, MA860KShares$292,5550.02% of portfolio
-
Russell Investments Group, Ltd.226KShares$76,8800.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA215KShares$72,9830.0% of portfolio
-
Potomac Capital Management, Inc.168KShares$57,0180.37% of portfolio
-
Black Rock Inc. New York, NY149KShares$50,6870.0% of portfolio
About BIOMERICA INC
- Ticker BMRA
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 13,427,700
- Market Cap $4.57M
- Description
- Biomerica, Inc., a biomedical technology company, develops, patents, manufactures, and markets diagnostic and therapeutic products for the detection and/or treatment of medical conditions and diseases worldwide. The company's diagnostic test kits are used to analyze blood, urine, or fecal specimens from patients in the diagnosis of various disea...